SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Lab reports Profit after tax of Rs 4197.00 Mln, in the March 2022 quarter

19 May 2022 Evaluate
The March 2022 quarter revenue stood at Rs. 36687.00 millions, up 9.49% as compared to Rs. 33507.00 millions during the corresponding quarter last year.The company has announced a 34.74% increase in its profits to Rs . 4197.00  millions for the  quarter ended March 2022 compared to Rs. 3115.00 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 7846.00 millions from 6845.00 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 36687.00 33507.00 9.49 144052.00 133491.00 7.91 144052.00 133491.00 7.91
Other Income 1147.00 816.00 40.56 4820.00 8011.00 -39.83 4820.00 8011.00 -39.83
PBIDT 7846.00 6845.00 14.62 30761.00 39379.00 -21.88 30761.00 39379.00 -21.88
Interest 127.00 169.00 -24.85 380.00 467.00 -18.63 380.00 467.00 -18.63
PBDT 7719.00 6676.00 15.62 30381.00 38912.00 -21.92 30381.00 38912.00 -21.92
Depreciation 2052.00 2107.00 -2.61 8143.00 8350.00 -2.48 8143.00 8350.00 -2.48
PBT 5667.00 4569.00 24.03 22238.00 30562.00 -27.24 22238.00 30562.00 -27.24
TAX 1470.00 1454.00 1.10 6006.00 8698.00 -30.95 6006.00 8698.00 -30.95
Deferred Tax 496.00 666.00 -25.53 2080.00 3297.00 -36.91 2080.00 3297.00 -36.91
PAT 4197.00 3115.00 34.74 16232.00 21864.00 -25.76 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 21.39 20.43 4.69 21.35 29.50 -27.61 21.35 29.50 -27.61

Dr. Reddys Labs. Share Price

1350.00 21.65 (1.63%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: